August 8, 2022

Healty

Slick Healthy

Curaleaf Launches Plant Precision, New Product Line

Plant Precision fills purchaser demand from customers for minimal dose THC formats that are geared to each day wellness as 75% of Us residents would contemplate employing cannabis for overall health and wellness needs*

WAKEFIELD, Mass., July 25, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Organization”), a leading global company of client products in hashish, nowadays introduced the launch of Plant Precision, a curated assortment of edibles and a topical gel developed to concentrate on particular wellness categories.

Plant Precision

In accordance to a Curaleaf / Harris Poll survey, 69% of People in america say they would be extra very likely to use hashish as a well being alternative if it came in small, managed doses*. Curaleaf acknowledged this need and established an approachable line for the newer wellness-oriented consumer that includes gummy edibles giving low, customizable doses of THC and substantial doses of non-psychoactive therapeutic minor cannabinoids like CBD, CBG, CBN and THCV, and a swiftly absorbent THC topical gel.

Plant Precision enables customers to investigate a selection of potentially therapeutic places this kind of as:

  • Harmony: an apple-flavored gummy made up of 2.5mg THC and 10mg CBD for waking up, winding down, or offering a instant of calm
  • Slumber: a cherry-flavored gummy containing 2.5mg THC and 10mg CBN which could be a handy addition to a nighttime schedule to enable slide (and keep) asleep
  • Soothe: a pineapple-flavored gummy containing 2.5mg THC and 10mg CBG for rebounding following vacation, extensive workouts, or lengthy weekends
  • Enhance: a lemon-flavored gummy made up of 2.5mg THC and 10mg THCV for setting up your day with a tiny further excitement
  • Relieve: a higher absorbing topical gel with 100% THC created to rapidly ease stress with a 30–45-minute onset time

The minor cannabinoids showcased in Plant Precision gummies are non-psychoactive and do not build the euphoric sensation like THC does, but as a substitute interact otherwise with the human receptor devices yielding diverse organic consequences. The Plant Precision gummies benefit from liposomal encapsulation, a technology which envelopes the cannabinoid molecules, to assist improve each and every milligram. Furthermore, each of the Plant Precision Gummy traces comprise formulated blends of terpenes that add to the entourage outcome, which takes place when minor cannabinoids interact with THC to generate a one of a kind effect with likely therapeutic rewards.

The Plant Precision Topical Gel was engineered employing hydro-alcoholic technological know-how to aid the supply of cannabinoids via the skin and has 650mg of full THC** – higher than almost all promoted THC topicals.

“With Plant Precision we wished to build a simplified way people can integrate hashish into their day-to-day wellness and wellness routines,” said Matt Darin, CEO of Curaleaf. “These solutions empower individuals to examine cannabis beyond THC and CBD and presents far more customizable answers on how the plant can best serve a consumer’s personalized desires.”

Plant Precision items will at first launch at Curaleaf destinations in 5 states now via August. The gummies*** and gel are available in Arizona and Massachusetts, with the gel also available in Florida, Nevada and Utah. For extra facts on merchandise availability, make sure you take a look at https://curaleaf.com/plant-precision.

These statements have not been evaluated by the Foodstuff and Drug Administration (Food and drug administration). These merchandise are not supposed to diagnose, take care of, heal, or avoid any condition. Maintain out of access of kids. Buyers really should seek the advice of with their doctor right before utilizing this products if they are pregnant, breastfeeding, or are having any drugs.

Investor Make contact with
Curaleaf Holdings, Inc.
Investor Relations
[email protected]

MEDIA Contact
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
[email protected]

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a major intercontinental company of consumer items in cannabis with a mission to improve life by giving clarity all-around cannabis and confidence all around use. As a high-advancement cannabis corporation acknowledged for good quality, expertise and reliability, the Business and its makes, together with Curaleaf and Decide on, present market-primary company, merchandise range and accessibility across the healthcare and adult-use markets. In the United States, Curaleaf currently operates in 22 states with 134 dispensaries, 26 cultivation web pages, and employs more than 5,700 team members. Curaleaf International is the premier vertically built-in hashish corporation in Europe with a exclusive source and distribution community all through the European sector, bringing together pioneering science and investigation with chopping-edge cultivation, extraction and production. Curaleaf is shown on the Canadian Securities Exchange underneath the image CURA and trades on the OTCQX market below the image CURLF. For a lot more information and facts, remember to visit https://ir.curaleaf.com.

Ahead On the lookout Statements
This media advisory is made up of forward–looking statements and forward–looking facts in just the that means of relevant securities guidelines. These statements relate to future events or potential overall performance. All statements other than statements of historic actuality might be forward–looking statements or details. Commonly, ahead-wanting statements and data might be identified by the use of ahead-searching terminology these kinds of as “options”, “expects” or, “proposed”, “is envisioned”, “intends”, “anticipates”, or “believes”, or variants of these words and phrases and phrases, or by the use of words and phrases or phrases which condition that particular steps, occasions or results may, could, would, or may well take place or be obtained. Far more especially and devoid of limitation, this news launch includes forward–looking statements and information and facts concerning the start of new Plant Precision products. These types of ahead-searching statements and facts replicate management’s recent beliefs and are dependent on assumptions produced by and details presently offered to the firm with respect to the issue explained in this new launch. Forward-seeking statements entail risks and uncertainties, which are centered on present expectations as of the day of this release and topic to acknowledged and not known challenges and uncertainties that could trigger precise success to vary materially from these expressed or implied by these types of statements. Further details about these assumptions and pitfalls and uncertainties is contained underneath “Risk Components and Uncertainties” in the Company’s most recent once-a-year information form filed March 9, 2022, which is available beneath the Firm’s SEDAR profile at http://www.sedar.com, and in other filings that the Business has produced and may well make with applicable securities authorities in the future. Forward-seeking statements contained herein are produced only as to the date of this press release and we undertake no obligation to update or revise any ahead-looking statements no matter if as a outcome of new information and facts, long run activities or usually, apart from as necessary by regulation. We warning traders not to place considerable reliance on the ahead looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, accepted or disapproved the articles of this information launch.

*Study Method:
This study was done on the web in the United States by The Harris Poll on behalf of Curaleaf from March 8-10, 2022, amongst 1,953 grownups ages 21+, among whom 1,095 have never ever made use of cannabis. The sampling precision of Harris online polls is calculated by working with a Bayesian credible interval.  For this review, the sample knowledge is exact to inside + 2.8 share factors working with a 95% confidence stage. For comprehensive study methodology, which include weighting variables and subgroup sample dimensions, be sure to get in touch with [email protected]

** Topical THC levels are 650mg unless in a condition where by polices have most THC policies, like MA

***Total selection of gummy availability dependent on the regulatory status of small cannabinoids (CBD, CBG, CBN, THCV) by state

Cision

See original written content to obtain multimedia:https://www.prnewswire.com/information-releases/curaleaf-launches-plant-precision-new-product or service-line-concentrating on-certain-wellness-and-wellness-classes-301591565.html

Resource Curaleaf Holdings, Inc.